טוען...
Minimax and admissible adaptive two-stage designs in phase II clinical trials
BACKGROUND: Simon’s two-stage design is the most widely implemented among multi-stage designs in phase II clinical trials to assess the activity of a new treatment in a single-arm study. In this two-stage design, the sample size from the second stage is fixed regardless of the number of responses ob...
שמור ב:
| הוצא לאור ב: | BMC Med Res Methodol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4969653/ https://ncbi.nlm.nih.gov/pubmed/27485595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12874-016-0194-3 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|